Time tO last ChemotherApy and death in ovaRian cancEr patients: TO CARE/MITO 42 study, a retrospective analysis of italian MITO centers.

Front Oncol · 2025 · PMC12364667 · PMID 40842572

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

Borderline significance was found for the C-reactive protein, which was tested at the start of the last chemotherapy in only 139 patients (23.1%): it was observed that 27.6% of patients with a C-reactive protein ≥5 received chemotherapy in the last 30 days of life, while 12.2% of patients with a C-reactive protein <5 received therapy (p=0.05).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.